Filing Flows › RXO (RXO) › Q3 2026 › vs Q3 2025
RXO (RXO) Q3 2026 vs Q3 2025 (year over year)
RXO's revenue rose $450M (+32%) from $1.4B in Q3 2025 to $1.9B in Q3 2026. Operating margin 0.9% against -0.5% (+1.4 pts).
RXO, Q3 2026: revenue $1.9B (+32% year over year), operating margin 0.9%, net earnings $3.0M, operating cash flow $25.0M. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Operating margin | 0.9% | -0.5% | +1.4 pts |
| Net margin | 0.2% | -1.0% | +1.1 pts |
| Free cash flow margin | 0.6% | 0.6% | +0.0 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $1.9B | $1.4B | $450M | +32% |
| Operating profit | $17.0M | −$7.0M | $24.0M | — |
| Costs & expenses | $1.9B | $1.4B | $426M | +30% |
| Pre-tax earnings | $6.0M | −$15.0M | $21.0M | — |
| Other expense, net | $11.0M | $8.0M | $3.0M | +38% |
| Cost of revenue | $1.5B | $1.1B | $401M | +35% |
| SG&A | $223M | $208M | $15.0M | +7% |
| Other operating costs | $93.0M | $83.0M | $10.0M | +12% |
| Net earnings | $3.0M | −$14.0M | $17.0M | — |
| Income tax | $3.0M | −$1.0M | $4.0M | — |
| Operating cash sources | $38.0M | $20.0M | $18.0M | +90% |
| Depreciation & amortization | $28.0M | $26.0M | $2.0M | +8% |
| Share-based compensation | $7.0M | $8.0M | −$1.0M | -12% |
| Working capital & other | $13.0M | −$3.0M | $16.0M | — |
| Operating cash flow | $25.0M | $23.0M | $2.0M | +9% |
| Free cash flow (OCF − capex) | $12.0M | $9.0M | $3.0M | +33% |
| Capital expenditures | $13.0M | $14.0M | −$1.0M | -7% |
Questions
How much did RXO's revenue grow year over year in Q3 2026?
RXO's revenue rose $450M (+32%) from $1.4B in Q3 2025 to $1.9B in Q3 2026. Operating margin 0.9% against -0.5% (+1.4 pts).